Madrigal Pharmaceuticals Stock Forecast - Day Median Price
| MDGL Stock | USD 343.97 14.73 4.47% |
Madrigal Stock Forecast is based on your current time horizon. Although Madrigal Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Madrigal Pharmaceuticals' systematic risk associated with finding meaningful patterns of Madrigal Pharmaceuticals fundamentals over time.
Madrigal |
| Previous Day Median Price | Day Median Price | Trend |
| 322.54 | 329.56 |
| Check Madrigal Pharmaceuticals Volatility | Backtest Madrigal Pharmaceuticals | Information Ratio |
Madrigal Pharmaceuticals Trading Date Momentum
| On November 22 2024 Madrigal Pharmaceuticals was traded for 343.97 at the closing time. The top price for the day was 343.97 and the lowest listed price was 315.15 . There was no trading activity during the period 0.0. Lack of trading volume on November 22, 2024 did not cause price change. The trading delta at closing time against the current closing price is 4.28% . |
The median price is the midpoint of the trading periods range.
| Compare Madrigal Pharmaceuticals to competition |
Other Forecasting Options for Madrigal Pharmaceuticals
For every potential investor in Madrigal, whether a beginner or expert, Madrigal Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Madrigal Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Madrigal. Basic forecasting techniques help filter out the noise by identifying Madrigal Pharmaceuticals' price trends.Madrigal Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Madrigal Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Madrigal Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Madrigal Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Madrigal Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Madrigal Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Madrigal Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Madrigal Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Madrigal Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Madrigal Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Madrigal Pharmaceuticals stock market strength indicators, traders can identify Madrigal Pharmaceuticals entry and exit signals to maximize returns.
Madrigal Pharmaceuticals Risk Indicators
The analysis of Madrigal Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Madrigal Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting madrigal stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.62 | |||
| Semi Deviation | 2.17 | |||
| Standard Deviation | 4.52 | |||
| Variance | 20.41 | |||
| Downside Variance | 6.03 | |||
| Semi Variance | 4.69 | |||
| Expected Short fall | (3.53) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Madrigal Pharmaceuticals to cross-verify your projections. For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Madrigal Pharmaceuticals. If investors know Madrigal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Madrigal Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (25.02) | Revenue Per Share 3.705 | Return On Assets (0.52) | Return On Equity (1.30) |
The market value of Madrigal Pharmaceuticals is measured differently than its book value, which is the value of Madrigal that is recorded on the company's balance sheet. Investors also form their own opinion of Madrigal Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Madrigal Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Madrigal Pharmaceuticals' market value can be influenced by many factors that don't directly affect Madrigal Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Madrigal Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Madrigal Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Madrigal Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.